Literature DB >> 1331094

15-Hydroxyeicosatetraenoic acid (15-HETE) receptors. Involvement in the 15-HETE-induced stimulation of the cryptic 5-lipoxygenase in PT-18 mast/basophil cells.

B M Vonakis1, J Y Vanderhoek.   

Abstract

The mechanisms of stimulation of the inactive 5-lipoxygenase in mast/basophil PT-18 cells by microM 15-hydroxyeicosatetraenoic acid (15-HETE) was investigated. Treatment of PT-18 cells with pM 15-[3H]HETE at 4 degrees for 3 h resulted in the cell association of 10% of the ligand: two-thirds was incorporated into cellular lipids and a third was bound to specific 15-HETE cellular binding sites. Binding data analysis indicated a single class of 15-HETE binding sites with a Kd of 162 nM and a Bmax of 7.1 x 10(5) sites/cell. Unlabeled 15-HETE, 12-HETE, and 5,15-diHETE inhibited the binding of 15-[3H]HETE to cells, whereas LTB4 and PGF2 alpha were relatively ineffective. 2.4 microM 15-HETE (unlabeled) prevented 50% 15-[3H]HETE incorporation. Examination of the effects of 15-HETE methyl ester, 12-HETE, 5,15-diHETE, and pertussis toxin on both the 15-HETE-induced 5-lipoxygenase activation and 15-HETE cell association processes indicated a preponderant correlation of this activation process with specific 15-HETE binding rather than 15-HETE incorporation into phospholipids. In addition, 5,15-diHETE itself stimulated the inactive 5-lipoxygenase and eight times more [3H]diHETE was bound to cells than became incorporated into cellular lipids. The results support the involvement of low affinity 15-HETE receptors, rather than 15-HETE incorporation into cellular lipids, in the 15-HETE-induced stimulation of the 5-lipoxygenase in PT-18 cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331094

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Vascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C ε-mediated zona occludens-1 phosphorylation at threonine 770/772.

Authors:  Rima Chattopadhyay; Elena Dyukova; Nikhlesh K Singh; Motoi Ohba; James A Mobley; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2013-12-15       Impact factor: 5.157

Review 2.  Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.

Authors:  William S Powell; Joshua Rokach
Journal:  Biochim Biophys Acta       Date:  2014-10-29

3.  NO synthase and guanylate cyclase inhibitors block modulation of the plasticity of common snail cholinoreceptors by 15-hydroxy-eicosatetraenoic acid.

Authors:  A S Pivovarov; W Egido-Villareal
Journal:  Neurosci Behav Physiol       Date:  1996 Sep-Dec

4.  Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium.

Authors:  S Takata; M Matsubara; P G Allen; P A Janmey; C N Serhan; H R Brady
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

5.  P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.

Authors:  Xuehong Liu; Catherine M Davis; Nabil J Alkayed
Journal:  Antioxid Redox Signal       Date:  2017-04-20       Impact factor: 8.401

Review 6.  Pro-Resolving Molecules-New Approaches to Treat Sepsis?

Authors:  Christa Buechler; Rebekka Pohl; Charalampos Aslanidis
Journal:  Int J Mol Sci       Date:  2017-02-23       Impact factor: 5.923

7.  Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals.

Authors:  Yvelise Ferro; Ilaria Carè; Elisa Mazza; Francesco Provenzano; Carmela Colica; Carlo Torti; Stefano Romeo; Arturo Pujia; Tiziana Montalcini
Journal:  Clin Mol Hepatol       Date:  2017-07-28

8.  Commentary: Mutual interaction of basophils and T cells in chronic inflammatory diseases.

Authors:  Salvatore Chirumbolo
Journal:  Front Immunol       Date:  2016-04-08       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.